BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/22/2025 9:25:54 AM | Browse: 56 | Download: 130
 |
Received |
|
2024-10-13 11:07 |
 |
Peer-Review Started |
|
2024-10-13 11:07 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-11-26 08:41 |
 |
Revised |
|
2024-12-05 03:15 |
 |
Second Decision |
|
2024-12-16 02:46 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-12-16 06:36 |
 |
Articles in Press |
|
2024-12-16 06:36 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2025-01-06 08:45 |
 |
Publish the Manuscript Online |
|
2025-01-22 09:25 |
ISSN |
1948-9366 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Letter to the Editor |
Article Title |
Harnessing the prognostic power of preoperative systemic immune-inflammation index/albumin ratio in hepatocellular carcinoma resection
|
Manuscript Source |
Invited Manuscript |
All Author List |
Zhao-Nan Zhang, Liang Hao, Shuang Han, Shan-Shan Li, Si-Xiang Lin and Yan-Dong Miao |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Shandong Province Medical and Health Science and Technology Development Plan Project |
202203030713 |
Science and Technology Program of Yantai Affiliated Hospital of Binzhou Medical University |
YTFY2022KYQD06 |
|
Corresponding Author |
Yan-Dong Miao, Cancer Center, Yantai Affiliated Hospital of Binzhou Medical University,The 2nd Medical College of Binzhou Medical University, No. 717 Jinbu Street, Muping District, Yantai 264100, Shandong Province, China. miaoyd_22@bzmc.edu.cn |
Key Words |
Hepatocellular carcinoma; Hepatocellular carcinoma; Inflammation; hepatocellular carcinoma resection |
Core Tip |
The study highlights the significance of the preoperative systemic immune-inflammation index/albumin (SII/ALB) ratio as an independent prognostic indicator for hepatocellular carcinoma patients undergoing curative resection. The SII/ALB ratio integrates inflammatory and nutritional biomarkers, providing a cost-effective and accessible tool for predicting overall and recurrence-free survival. Additionally, a predictive nomogram incorporating SII/ALB with clinical parameters improves patient stratification, guiding surgical decisions and postoperative care. While promising, further multi-center validation across diverse patient populations is needed to confirm its broad clinical applicability. Moreover, dynamic monitoring of SII/ALB throughout treatment could enhance personalized therapy, making it a valuable asset even in resource-limited healthcare settings. |
Publish Date |
2025-01-22 09:25 |
Citation |
<p>Zhang ZN, Hao L, Han S, Li SS, Lin SX, Miao YD. Harnessing the prognostic power of preoperative systemic immune-inflammation index/albumin ratio in hepatocellular carcinoma resection. <i>World J Gastrointest Surg</i> 2025; 17(2): 102261</p> |
URL |
https://www.wjgnet.com/1948-9366/full/v17/i2/102261.htm |
DOI |
https://dx.doi.org/10.4240/wjgs.v17.i2.102261 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345